회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 생명공학 > 바이오테크놀로지
Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019
발행사 MarketsandMarkets

발행일 2015-05
분량 154 pages
서비스형태 Report
판매가격

인쇄하기

In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. The genome editing market, by technology, is categorized into CRISPR, TALEN, ZNF, antisense technology, and other technologies. The end-user segment includes biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia; and North America is divided into Canada and the U.S.

Growth in the genome editing market is mainly driven by the increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, technological advancements, increasing demand for synthetic genes, and global rise in production of genetically modified crops. The high growth potential in emerging markets provides new growth opportunities to players in the genome editing market.

A combination of the bottom-up and top-down approach was used to calculate the market sizes and growth rates of the global genome editing market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of the genome editing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each segment and identifies the segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the genome editing market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as mergers and acquisitions; agreements, collaborations, and partnerships; expansions; and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of the top players in the genome editing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the genome editing market

• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the genome editing market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various genome editing segments across geographies

• Market Diversification: Exhaustive information about new products, recent developments, and investments in the genome editing market


회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.